NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE4805.50105 (+2.23 %)
PREV CLOSE ( ) 4700.50
OPEN PRICE ( ) 4720.05
BID PRICE (QTY) 4795.65 (1)
OFFER PRICE (QTY) 4805.00 (1)
VOLUME 386
TODAY'S LOW / HIGH ( )4713.00 4808.40
52 WK LOW / HIGH ( )4595.85 5640
NSE4803.00101.9 (+2.17 %)
PREV CLOSE( ) 4701.10
OPEN PRICE ( ) 4701.10
BID PRICE (QTY) 4800.50 (1)
OFFER PRICE (QTY) 4803.00 (87)
VOLUME 3781
TODAY'S LOW / HIGH( ) 4701.05 4810.00
52 WK LOW / HIGH ( )4575 5642.85
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1967
Management Info
Suresh Talwar - Chairman Milind Thatte - Managing Director
Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (E),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
27Mar Procter & Gamble Hygiene and Health Ca
Procter & Gamble Hygiene and Health Care has informed that the Compa..
04Mar Procter & Gamble Health informs about
Procter & Gamble Health has informed that it has received informatio..
06Feb Procter & Gamble Health informs about
Procter & Gamble Health has informed that the Board has approved int..
20Jan Procter & Gamble Health informs about
Procter & Gamble Health has informed that it has been informed by it..
21Dec Procter & Gamble Health informs about
Procter & Gamble Health has informed that it received intimation fro..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit720.72294.7
Gross Profit 997.2 3142
Operating Profit 1068.33430.7
Net Sales 3099.712296.2
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Mankind Pharma (BSE)
 2399.95 (2.66%)
M.Cap (Rs. in Cr)96055.10
Torrent Pharma (BSE)
 2641.05 (1.94%)
M.Cap (Rs. in Cr)89347.90
Astrazeneca Pharma I (BSE)
 5266.75 (0.94%)
M.Cap (Rs. in Cr)13166.88
Fredun Pharma (BSE)
 812.05 (6.12%)
M.Cap (Rs. in Cr)386.94
Divi's Lab (BSE)
 3772.35 (0.98%)
M.Cap (Rs. in Cr)99550.72
MORE
Shareholding Pattern
PROMOTERS 51.82%
NON-INSTITUTION 28.21%
MUTUAL FUNDS/UTI 9.86%
FI/BANKS/INSURANCE 3.55%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.